Announcements Trials
Browse Landscape

Status

Recruiting 7Not yet recruiting 6Completed 6Active not recruiting 3Unknown 1Terminated 1Approved for marketing 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Small Cell Lung Carcinoma 1

Interventions

trilaciclib 1PM 01183 1AMG 757 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Approved for marketing × Small Cell Lung Carcinoma × PM 01183 × Clear all
NCT04291937 2020-06-19

A Multicenter Expanded Access Treatment Protocol of Lurbinectedin in Previously Treated SCLC in the USA

Jazz Pharmaceuticals

Approved for marketing
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡